These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 21325652)

  • 1. Cerebrovascular risk factors and preclinical memory decline in healthy APOE ε4 homozygotes.
    Caselli RJ; Dueck AC; Locke DE; Sabbagh MN; Ahern GL; Rapcsak SZ; Baxter LC; Yaari R; Woodruff BK; Hoffman-Snyder C; Rademakers R; Findley S; Reiman EM
    Neurology; 2011 Mar; 76(12):1078-84. PubMed ID: 21325652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal modeling of frontal cognition in APOE ε4 homozygotes, heterozygotes, and noncarriers.
    Caselli RJ; Dueck AC; Locke DE; Hoffman-Snyder CR; Woodruff BK; Rapcsak SZ; Reiman EM
    Neurology; 2011 Apr; 76(16):1383-8. PubMed ID: 21502596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.
    Caselli RJ; Reiman EM; Locke DE; Hutton ML; Hentz JG; Hoffman-Snyder C; Woodruff BK; Alexander GE; Osborne D
    Arch Neurol; 2007 Sep; 64(9):1306-11. PubMed ID: 17846270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriers.
    Stonnington CM; Snyder PJ; Hentz JG; Reiman EM; Caselli RJ
    J Clin Psychiatry; 2009 Oct; 70(10):1379-84. PubMed ID: 19573495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect.
    Caselli RJ; Dueck AC; Osborne D; Sabbagh MN; Connor DJ; Ahern GL; Baxter LC; Rapcsak SZ; Shi J; Woodruff BK; Locke DE; Snyder CH; Alexander GE; Rademakers R; Reiman EM
    N Engl J Med; 2009 Jul; 361(3):255-63. PubMed ID: 19605830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of β-Amyloid and Apolipoprotein E ε4 With Memory Decline in Preclinical Alzheimer Disease.
    Lim YY; Kalinowski P; Pietrzak RH; Laws SM; Burnham SC; Ames D; Villemagne VL; Fowler CJ; Rainey-Smith SR; Martins RN; Rowe CC; Masters CL; Maruff PT
    JAMA Neurol; 2018 Apr; 75(4):488-494. PubMed ID: 29356823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal changes in cognition and behavior in asymptomatic carriers of the APOE e4 allele.
    Caselli RJ; Reiman EM; Osborne D; Hentz JG; Baxter LC; Hernandez JL; Alexander GG
    Neurology; 2004 Jun; 62(11):1990-5. PubMed ID: 15184602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A distinctive interaction between memory and chronic daytime somnolence in asymptomatic APOE e4 homozygotes.
    Caselli RJ; Reiman EM; Hentz JG; Osborne D; Alexander GE; Boeve BF
    Sleep; 2002 Jun; 25(4):447-53. PubMed ID: 12071547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APOE epsilon4 genotype and longitudinal changes in cerebral blood flow in normal aging.
    Thambisetty M; Beason-Held L; An Y; Kraut MA; Resnick SM
    Arch Neurol; 2010 Jan; 67(1):93-8. PubMed ID: 20065135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical memory decline in cognitively normal apolipoprotein E-epsilon4 homozygotes.
    Caselli RJ; Graff-Radford NR; Reiman EM; Weaver A; Osborne D; Lucas J; Uecker A; Thibodeau SN
    Neurology; 1999 Jul; 53(1):201-7. PubMed ID: 10408560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aβ-related memory decline in APOE ε4 noncarriers: Implications for Alzheimer disease.
    Lim YY; Laws SM; Villemagne VL; Pietrzak RH; Porter T; Ames D; Fowler C; Rainey-Smith S; Snyder PJ; Martins RN; Salvado O; Bourgeat P; Rowe CC; Masters CL; Maruff P
    Neurology; 2016 Apr; 86(17):1635-42. PubMed ID: 27029632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neuropsychology of normal aging and preclinical Alzheimer's disease.
    Caselli RJ; Locke DE; Dueck AC; Knopman DS; Woodruff BK; Hoffman-Snyder C; Rademakers R; Fleisher AS; Reiman EM
    Alzheimers Dement; 2014 Jan; 10(1):84-92. PubMed ID: 23541188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid and APOE ε4 interact to influence short-term decline in preclinical Alzheimer disease.
    Mormino EC; Betensky RA; Hedden T; Schultz AP; Ward A; Huijbers W; Rentz DM; Johnson KA; Sperling RA; ; ;
    Neurology; 2014 May; 82(20):1760-7. PubMed ID: 24748674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease genetic risk and cognitive reserve in relationship to long-term cognitive trajectories among cognitively normal individuals.
    Pettigrew C; Nazarovs J; Soldan A; Singh V; Wang J; Hohman T; Dumitrescu L; Libby J; Kunkle B; Gross AL; Johnson S; Lu Q; Engelman C; Masters CL; Maruff P; Laws SM; Morris JC; Hassenstab J; Cruchaga C; Resnick SM; Kitner-Triolo MH; An Y; Albert M
    Alzheimers Res Ther; 2023 Mar; 15(1):66. PubMed ID: 36978190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APOE-epsilon4 is associated with memory decline in cognitively impaired elderly.
    Dik MG; Jonker C; Bouter LM; Geerlings MI; van Kamp GJ; Deeg DJ
    Neurology; 2000 Apr; 54(7):1492-7. PubMed ID: 10751265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypometabolism in Alzheimer-affected brain regions in cognitively healthy Latino individuals carrying the apolipoprotein E epsilon4 allele.
    Langbaum JB; Chen K; Caselli RJ; Lee W; Reschke C; Bandy D; Alexander GE; Burns CM; Kaszniak AW; Reeder SA; Corneveaux JJ; Allen AN; Pruzin J; Huentelman MJ; Fleisher AS; Reiman EM
    Arch Neurol; 2010 Apr; 67(4):462-8. PubMed ID: 20385913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depressive symptoms in healthy apolipoprotein E ε4 carriers and noncarriers: a longitudinal study.
    Locke DE; Dueck AC; Stonnington CM; Knopman DS; Geda YE; Caselli RJ
    J Clin Psychiatry; 2013 Dec; 74(12):1256-61. PubMed ID: 24434095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential Associations of Apolipoprotein E ε4 Genotype With Attentional Abilities Across the Life Span of Individuals With Down Syndrome.
    D'Souza H; Mason L; Mok KY; Startin CM; Hamburg S; Hithersay R; Baksh RA; Hardy J; Strydom A; Thomas MSC;
    JAMA Netw Open; 2020 Sep; 3(9):e2018221. PubMed ID: 32986108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid-Related Memory Decline in Preclinical Alzheimer's Disease Is Dependent on APOE ε4 and Is Detectable over 18-Months.
    Thai C; Lim YY; Villemagne VL; Laws SM; Ames D; Ellis KA; Rainey-Smith SR; Martins RN; Masters CL; Rowe CC; Maruff P;
    PLoS One; 2015; 10(10):e0139082. PubMed ID: 26430784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein-E (Apoe) ε4 and cognitive decline over the adult life course.
    Rawle MJ; Davis D; Bendayan R; Wong A; Kuh D; Richards M
    Transl Psychiatry; 2018 Jan; 8(1):18. PubMed ID: 29317609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.